Evidence map›Paper›PMID 33154202›Full record

ArticleAsian journal of andrology

Prevalence of late-onset hypogonadism among middle-aged and elderly males in China: results from a national survey.

Yi-Jun Liu, Xu-Bo Shen, Na Yu, Xue-Jun Shang, Yi-Qun Gu, Lian-Dong Zuo, Cheng-Liang Xiong, Zhen Ye, Yuan-Zhong Zhou

Open access · goldAbstract read
In one paragraph

Article in Asian journal of andrology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Epidemiology of Male Hypogonadism.Endocrinology and metabolism clinics of North America · 2022
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Yi-Jun LiuSchool of Public Health, Zunyi Medical University, Zunyi 563000, China.
Xu-Bo ShenSchool of Public Health, Zunyi Medical University, Zunyi 563000, China.
Na YuScientific Research Center, The Third Affiliated Hospital of Guang Dong Medical University (Long Jiang Hospital of Shunde District Foshan City), Foshan 528318, China.
Xue-Jun ShangDepartment of Andrology, Eastern Theater General Hospital, Nanjing 210002, China.
Yi-Qun GuInstitute of Science and Technology, National Research Institute for Family Planning, Beijing 100081, China.
Lian-Dong ZuoGuangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510632, China.
Cheng-Liang XiongFamily Planning Research Institute, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Zhen YeDepartment of Urology and Andrology, Wuhan Tongji Reproductive Medicine Hospital, Wuhan 430013, China.
Yuan-Zhong ZhouSchool of Public Health, Zunyi Medical University, Zunyi 563000, China.
Zunyi Medical University · CNGuangzhou Medical University · CNHuazhong University of Science and Technology · CNTongji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to propose an operational definition of late-onset hypogonadism (LOH) that incorporates both clinical symptoms and serum testosterone measurements to evaluate the prevalence of LOH in aging males in China. A population-based sample of 6296 men aged 40 years-79 years old was enrolled from six representative provinces in China. Serum total testosterone (TT), sex hormone-binding globulin (SHBG), and luteinizing hormone (LH) were measured and free testosterone (cFT) was calculated. The Aging Males' Symptoms (AMS) scale was used to evaluate the LOH symptoms. Finally, 5078 men were included in this analysis. The TT levels did not decrease with age (P = 0.59), and had no relationship with AMS symptoms (P = 0.87 for AMS total score, P = 0.74 for ≥ 3 sexual symptoms). The cFT levels decreased significantly with age (P < 0.01) and showed a negative association with the presence of ≥ 3 sexual symptoms (P = 0.03). The overall estimated prevalence of LOH was 7.8% (395/5078) if a cFT level <210 pmol l

Indexed as

AdultAgedAge FactorsAge of OnsetChinaComorbidityHumansHypogonadismLuteinizing HormoneMaleMiddle AgedPrevalenceSex Hormone-Binding GlobulinTestosteroneLuteinizing HormoneSex Hormone-Binding GlobulinTestosteroneAging Males' Symptomscalculated free testosteronelate-onset hypogonadismmiddle-aged and elderly maletotal testosterone

Identifiers

PMID33154202
PMCPMC7991815
OpenAlexW3096037762

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.